INTRODUCTION
============

Spinal osteophytosis is a common disease in the elderly population. More than 75% of people over 65 years old have age-related changes in cervical vertebra anatomy \[[@b1-arm-2019-43-1-27]\]. There are various causes for the development of anterior cervical osteophytes (ACOs). The majority of cervical osteophytes occur due to degenerative diseases. Other causes for the development of anterior osteophytes include diffuse idiopathic skeletal hyperostosis (DISH), failure of surgery, adjacent segmental instabilities after fusion, heterotopic ossification after cervical disc arthroplasty, and posttraumatic instabilities \[[@b2-arm-2019-43-1-27],[@b3-arm-2019-43-1-27]\]. Most of the time, an ACO does not present with any accompanying symptoms. However, prominent ACOs can cause dysphonia, dyspnea, dysphagia, and pain \[[@b4-arm-2019-43-1-27]\]. Dysphagia is the most common presentation of symptomatic ACOs \[[@b3-arm-2019-43-1-27]\]. According to Granville et al. \[[@b5-arm-2019-43-1-27]\], 10.6% of people presenting with dysphagia have cervical osteophytes. According to Utsinger et al. \[[@b6-arm-2019-43-1-27]\], 17% of patients with cervical osteophytosis develop dysphagia.

ACOs could be isolated or diffuse. They are most often idiopathic as a part of the disease entity called DISH \[[@b1-arm-2019-43-1-27]\]. DISH is characterized radiologically by flowing calcification along anterolateral sides of contiguous vertebrae of the spine \[[@b7-arm-2019-43-1-27]\]. Secondary dysphagia due to DISH has been frequently described in case reports \[[@b2-arm-2019-43-1-27]\]. There are no treatment guidelines for dysphagia induced by ACOs. Several cases have described the effect of surgical management on symptomatic osteophytes \[[@b3-arm-2019-43-1-27]\]. However, evidence for surgical approach remains insufficient.

The aim of this study was to analyze swallowing characteristics of dysphagic patients with ACOs and compare clinical courses according to different treatment options.

MATERIALS AND METHODS
=====================

Subjects and study design
-------------------------

This was a retrospective study of 1,866 patients who had dysphagia with videofluoroscopic swallowing study (VFSS) at Inje University Haeundae Paik Hospital from April 2014 to December 2017. Eligibility criteria were: (1) patients who had VFSS performed for evaluation of dysphagia and (2) those with ACOs of the cervical spine confirmed by radiologic study. Patients with brain lesions, neuromuscular disease, or other causes that could explain their dysphagia were excluded. A total of 1,866 patients who had VFSS were identified in the electronic medical record (EMR) and reviewed. Twenty-three patients met the eligibility criteria. These 23 patients were enrolled and classified into three groups. Patients who underwent surgery for ACOs were classified into group A (n=4). Those who received swallowing rehabilitation were assigned into group B (n=9) and those who received conservative treatment were classified into group C (n=10). Conservative treatment included diet modification and medications such as muscle relaxants and antiinflammatories \[[@b2-arm-2019-43-1-27]\]. This study was performed according to the Declaration of Helsinki. It was approved by the Institutional Review Board of Inje University Haeundae Paik Hospital (No. 2016-12-013). Subject enrollment and flow are shown in [Fig. 1](#f1-arm-2019-43-1-27){ref-type="fig"}.

Swallowing and ACO assessment
-----------------------------

A VFSS was performed by two medical doctors and one occupational therapist. Patients were seated upright on a fluoroscopy chair or wheelchair. The protocol of VFSS in Inje University Haeundae Paik Hospital started with a lateral scout neck image, including cervical spine. The image was taken on the lateral plane and included lips anterior to the vertebrae and the soft palate superior to the 6th cervical vertebra \[[@b8-arm-2019-43-1-27]\]. Barium sulfate powder was used for fluorescence and mixed with either water, liquid diet (water rice gruel), soft diet (rice gruel), or solid diet (rice). Each type of barium diet was then swallowed by the patient. Imaging was then recorded. The anterior-posterior view was also assessed. Two physiatrists analyzed VFSS results. If the patient visibly aspirated on the videofluoroscopy, they did not progress to the next test diet.

In this study, ACO or DISH was well visualized on scout images of VFSS and on plain lateral radiographs of the cervical spine. Radiologic findings of ACO were also assessed by two physiatrists. The affected level(s) and the thickest level of ACO were identified. The thickness of the most prominent ACO was measured. ACOs were classified into three types: segmental, continuous, and mixed \[[@b9-arm-2019-43-1-27]\].

Outcome measurements
--------------------

Demographic and clinical dysphagia characteristics, dysphagia severity, and VFSS findings of subjects were evaluated. Swallowing characteristics and clinical courses were compared among the three treatment groups. Clinical characteristics related to swallowing were measured using numerical (from 0 to 100) clinical dysphagia scale (CDS) \[[@b9-arm-2019-43-1-27]\]. Dysphagia severity was assessed using the American Speech-Language-Hearing Association National Outcomes Measurement System (ASHA NOMS) swallowing scale and the videofluoroscopic dysphagia scale (VDS). VDS is a numerical scale (from 0 to 100) that measures VFSS findings as objective, quantitative scores directly converted from physiologic parameters of the VFSS \[[@b10-arm-2019-43-1-27]\]. It was created using prognostic factors known to be reliable, objective, and quantifiable predictors of long-term persistent dysphagia after stroke \[[@b11-arm-2019-43-1-27]\]. It has been previously noted that the VDS is a useful scale for quantifying the severity of dysphagia in various disease and age groups \[[@b10-arm-2019-43-1-27]\].

Each parameter of VDS was used to compare VFSS findings. The VDS consisted of two phases: oral phase and pharyngeal phase. Scores and parameters of each phase were compared among the three groups. Temporal parameters such as oral transit time (OTT), pharyngeal delay time (PDT), and pharyngeal transit time (PTT) were also measured and compared. Definitions of above parameters have been published previously \[[@b12-arm-2019-43-1-27]\]. In addition, clinical courses were compared among the three groups using the ASHA NOMS swallowing scale and VDS scores at 3 months after the initial VFSS.

Correlations between treatment options and various characteristics of patients
------------------------------------------------------------------------------

As mentioned above, subjects were divided into three groups: those who received surgery (group A), patients who participated in swallowing rehabilitation (group B), and those who opted for conservative treatment (group C). Various characteristics suspected to be associated with these treatment options in these dysphagic patients with ACOs were investigated. Patients' demographics, clinical swallowing characteristics, radiologic findings, dysphagia severity, and VFSS findings were used to analyze their correlations with treatment options.

Statistical analysis
--------------------

Data analyses were performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). Sociodemographic, osteophyte-specific, and swallowing characteristics of subjects were analyzed using descriptive statistics that included frequency, percentage, and mean±standard deviation. To compare gender, clinical dysphagic symptoms, comorbidity, and osteophyte level, Pearson chi-square and Fisher exact tests were used. When comparing three groups, one-way ANOVA or Kruskal-Wallis test was used depending on the normality of data distribution. If necessary, post-hoc analysis (Scheffe) was done. Spearman rank correlation analysis was also performed to identify correlation of treatment options with other characteristics. All tests were two-tailed and a p-value of less than 0.05 was considered statistically significant.

RESULTS
=======

Demographic and clinical characteristics of patients
----------------------------------------------------

Demographics and clinical characteristics of ACO patients are summarized in [Table 1](#t1-arm-2019-43-1-27){ref-type="table"}. This study included 22 men and 1 woman. Their mean age was 78.69±8.01 years (range, 62--89 years). Average dysphagia symptom duration was 96.91±205.19 days. In group A, 3 patients had DISH-induced ACO and 1 patient had cervical osteoarthritis (OA). In group B, DISH was observed in 5 patients whereas cervical OA was noted in the other 4 patients. Likewise, in group C, 3 patients had DISH whereas the remaining 7 patients had cervical OA. No significant difference in the etiology was found among the three groups (p=0.298).

The most common CDS findings included inadequate laryngeal elevation (87.0%), aspiration (69.6%), and reflex coughing (60.9%). Lip sealing and tongue protrusion in oral function were intact in 87.0% and 60.9% of subjects, respectively. In the surgical group, all subjects maintained their oral function. The most commonly associated symptom was choking, followed by aspiration pneumonia. There was no significant intergroup difference in age, gender, symptom duration, or other combined symptoms and comorbidities. The most common comorbid conditions were arthritis, hypertension, type 2 diabetes mellitus, and coronary artery disease. All subjects had arthritis.

Radiologic findings of ACO
--------------------------

Of 23 patients, C5 (n=20) was the most commonly affected level, followed by C6 (n=18), and C4 (n=16). In group A, all patients had osteophytes at levels C3, C4, and C5. In groups B and C, C5 and C5-6 levels were the most commonly affected. There were no intergroup differences in most affected levels. The level with the thickest osteophytes was C5 (n=8), followed by C6 (n=6) and C4 (n=5). Level C4 was the thickest level in group A. It had a significant intergroup difference (p=0.009). The mean osteophyte thickness was 9.07±3.84 mm (range, 3--18 mm). Average thicknesses of groups A, B, and C were 13.13 mm, 7.83 mm and 8.55 mm, respectively. Osteophytes in group A were significantly thicker than those in the other groups (p=0.01). Overall, 9 cases were classified as segmental type ACOs, 7 cases as continuous type, and 7 cases as mixed type ACOs. The type of osteophytes and the number of affected levels showed no significant intergroup difference ([Table 2](#t2-arm-2019-43-1-27){ref-type="table"}).

Dysphagia severity and swallowing characteristics in patients with ACO
----------------------------------------------------------------------

The mean CDS score showed no significant inter-group difference (45.00±26.77 in group A vs. 43.44±14.81 in group B vs. 32.5±15.1 in group C). With all patients included, mean ASHA NOMS swallowing scale and VDS scores were 2.17±1.58 and 40.04±10.06, respectively. Dysphagia severity showed no significant inter-group difference in ASHA NOMS swallowing scale (2.25±0.83 in group A vs. 1.44±1.25 in group B vs. 2.90±1.64 in group C) or VDS (53.13±6.66 in group A vs. 49.22±9.35 in group B vs. 44.85±14.37 in group C). However, the pharyngeal phase score of the VDS showed significant intergroup difference (p=0.041). The pharyngeal phase score of group A was higher than that of group C. The most common VFSS finding included penetration (100%), decreased laryngeal elevation (91.3%), and reduced epiglottis inversion (87.0%). In group A, all patients showed incomplete upper esophageal sphincter (UES) opening in addition to the above findings, with residue in the valleculae and pyriform sinuses. Incomplete UES opening had a significant intergroup difference (p=0.016). However, temporal parameter such as OTT, PDT, or PTT showed no significant inter-group difference ([Table 3](#t3-arm-2019-43-1-27){ref-type="table"}).

Clinical courses in dysphagic patients with ACO
-----------------------------------------------

Of the 23 ACO patients, 4 underwent surgical intervention. After surgery, 3 patients who could not swallow anything safely were able to eat orally. The remaining patient improved from level 4 to level 7 in ASHA NOMS swallowing scale. In all three groups, there were no significant intra-group differences in ASHA NOMS swallowing scale after treatment. However, group A showed a trend toward statistically significant improvement (p=0.059). Followup evaluation using ASHA NOMS swallowing scale demonstrated a significant inter-group difference (p=0.009). The score of group A was increased more than that in the other two groups. Dysphagia severity according to ASHA NOMS swallowing scale after treatment also showed inter-group differences between group with surgical treatment and groups without surgical treatment (p=0.047).

Ten patients underwent follow-up VFSS at 3 months after the initial procedure. The mean change in VDS score was 27.0±6.36 for group A, 1.9±8.61 for group B, and 1.5±6.87 for group C, showing significant inter-group difference (p=0.014). In post-hoc analysis, group A showed significant change in the follow-up VDS score than the other groups ([Table 4](#t4-arm-2019-43-1-27){ref-type="table"}). Two patients in the surgical group underwent follow-up VFSS. After surgical treatment, their pharyngeal phase scores were decreased by 16.5 and 31.5, respectively. Based on VDS item, the amount of residue in the pyriform sinus was decreased. Moreover, aspiration and penetration showed improvement.

Correlations between treatment options and various characteristics in patients with ACO
---------------------------------------------------------------------------------------

C3 osteophyte level, pharyngeal phase score of VDS, inadequate bolus formation, reduced epiglottis inversion, and incomplete UES opening showed significant correlations with treatment options. The correlation between pharyngeal phase score of VDS and treatment options was the largest, followed by incomplete UES opening and C3 osteophyte level ([Table 5](#t5-arm-2019-43-1-27){ref-type="table"}).

DISCUSSION
==========

In this study, 22 of 23 patients (96%) were males. Their mean age was 78.7 years. A meta-analysis study of 204 cases by Verlaan et al. \[[@b13-arm-2019-43-1-27]\] has reported that the maleto-female ratio of ACO incidence is 6.1:1 and the average age is 68.9 years. Kim et al. \[[@b14-arm-2019-43-1-27]\] have reported that ACOs occur more frequently in men and that the average age at onset is 66 years. This is generally consistent with our study demographics. ACOs were reported in 2.9% to 4.1% of adults in Korea \[[@b14-arm-2019-43-1-27]\]. Its prevalence is known to increase with age \[[@b14-arm-2019-43-1-27]\]. Seidler et al. \[[@b15-arm-2019-43-1-27]\] have found that the dysphagic symptom severity increases with age. Because life expectancy is increasing, the prevalence of dysphagia due to ACOs may also increase in the coming decades \[[@b14-arm-2019-43-1-27]\].

Spondylosis is a common finding in the aging cervical spine \[[@b16-arm-2019-43-1-27]\]. ACOs can be a result of such degenerative disorders of the cervical spine. Indeed, in this study, all participants had arthritis. Symptomatic degenerative changes of the cervical spine affect approximately 75% of the population aged more than 60 years \[[@b16-arm-2019-43-1-27]\]. Therefore, older male patients with unexplained dysphagia may need to evaluate cervical spine for possible ACOs.

The main findings of this study were that swallowing characteristics of dysphagic patients with ACOs showed pharyngeal phase dysphagia including penetration, decreased laryngeal elevation, and reduced epiglottis inversion. The surgical group had a significant higher pharyngeal phase score of VDS than the other groups. Moreover, in the surgical group, the thickest and most affected level of ACO were at higher level of the cervical spine and their ACOs were significantly thicker than the other two groups.

Although some studies have suggested various mechanisms to account for ACO-induced dysphagia, the exact mechanisms remain unclear. Dysphagia due to ACO is most commonly associated with anterior osteophyte formation at C3-5 levels. This might be due to the fact that the normal epiglottic tilt lies over the laryngeal inlet at these levels \[[@b13-arm-2019-43-1-27]\]. In this study, all patients in group A had ACOs at C3-5 levels and showed reduced epiglottis inversion, decreased laryngeal elevation, and penetration on VFSS findings. According to Di Vito \[[@b17-arm-2019-43-1-27]\], bolus deflects off directly into the open larynx because of the shelf formed by an anterior osteophyte at C3-5 levels. This has been reported to cause direct aspiration \[[@b17-arm-2019-43-1-27]\]. Seidler et al. \[[@b15-arm-2019-43-1-27]\] have reported that osteophytes at C3-4 and C4-5 levels are associated with aspiration during swallowing due to restriction of the epiglottic closure. This type of aspiration was more common in patients of group A who had ACOs at higher cervical spine levels. In contrast, residue retention with possible post-swallow aspiration is often found in patients with osteophytes in lower cervical spine levels (C5-6, C6-7) \[[@b15-arm-2019-43-1-27]\]. Osteophytes at the C6-7 level can cause esophageal impingement or obstruction \[[@b17-arm-2019-43-1-27]\]. Group C had more osteophytes at C6-7 level. However, esophageal impingement or obstruction was not detected on VFSS. This suggests that osteophytes might not be thick enough to cause such conditions.

According to Strasser et al. \[[@b18-arm-2019-43-1-27]\], aspiration is rare in patients with osteophytes \<10 mm. They found that clinically relevant obstruction of the pharynx occurred from about 12 to 15 mm osteophyte thickness. Seidler et al. \[[@b15-arm-2019-43-1-27]\] have reported that osteophytes \>10 mm in the anteriorposterior length could lead to symptoms related to dysphagia. In our study, osteophyte thickness in group A was 13.13±2.26 mm, which was significantly thicker than that in other groups. The mean osteophyte thickness was 9.07±3.84 mm (range, 3--18 mm). These findings were consistent with results of other studies. The thickness of the osteophyte can affect the epiglottic tilt or direct aspiration into the larynx. It can also cause physical obstruction of the esophageal lumen. In addition, increased thickness may increase the incidence and severity of symptoms such as choking and aspiration. In the present study, the surgical group showed significantly higher scores in pharyngeal phase of VDS than the other groups. This suggests that laryngeal dysfunction along with aspiration may influence the decision to undergo surgical treatment.

There is no consensus about proper ACO treatments at this time. Most case reports and studies have reported improvements in dysphagia symptoms within 6 weeks after surgical treatment. von der Hoeh et al. \[[@b2-arm-2019-43-1-27]\] have reported improvements in VFSS findings and dysphagia symptoms in all their six patients after surgery. Flynn \[[@b19-arm-2019-43-1-27]\] have reported improvement of dysphagia symptoms in 28 of 30 patients after surgical resection of ACOs. In our study, the surgical group showed significant improvements in their dysphagia severity compared to the other treatment groups. The swallowing rehabilitation group did not show significant improvement in dysphagia severity. This might be due to the small sample size, short follow-up duration after swallowing rehabilitation, and difficult structural changes in osteophytes. However, swallowing rehabilitation has been suggested as a treatment option because neuromuscular strengthening and diet modification can help improve patients' symptoms \[[@b20-arm-2019-43-1-27]-[@b22-arm-2019-43-1-27]\].

Based on EMR review, patients with thick ACO and definite aspiration were recommended to undergo surgery. In the surgical group, 3 out of 4 patients were referred to a neurosurgeon after VFSS in the rehabilitation department while the other patient underwent orthopedic surgery recommended by the otolaryngologist. In the swallowing rehabilitation group, 2 out of 9 patients refused surgery but underwent rehabilitation and 2 patients were unable to undergo an operation due to the presence of comorbidities. The remaining 5 patients were determined to conduct swallowing rehabilitation by an internist. Moreover, we compared VDS total score (40.50±6.47, 39.30±10.30) and VDS pharyngeal phase score (32.75±7.96, 33.90±8.32) of patients who were recommended for surgical treatment and those who were determined to initially undergo rehabilitation. There was no statistically significant difference (p=1.0 and p=0.905, respectively). In the conservative treatment group, 1 of 10 patients refused the recommended surgical treatment and 7 patients refused the swallowing rehabilitation. Two patients were isolated. Hence, rehabilitation was not performed. For patients with dysphagia caused by ACO, surgical indication or treatment method has not been established yet. Therefore, selection of treatment option by patient might have influenced the final decision of the treatment method.

Characteristics associated with treatment options in dysphagic patients with ACOs were analyzed. ACOs at C3 level had positive correlations with treatment options. Those in the more active treatment groups such as patients who underwent surgery and swallow rehabilitation had frequent alterations on the upper cervical spine, especially at the C3 level. A systematic review of 204 cases by Verlaan et al. \[[@b13-arm-2019-43-1-27]\] has elucidated that the most affected vertebrae are C3, C4, and C5 known to be associated with epiglottic tilt. Based on the study by Bartalena et al. \[[@b23-arm-2019-43-1-27]\], VFSS shows epiglottis impingement at C3--C4 level which alters the pharyngeal phase of swallowing and leads to laryngeal penetration. von der Hoeh et al. \[[@b2-arm-2019-43-1-27]\] have also reported that most surgeries are performed at C3--C4 level. Osteophytes at the C3--C5 level may cause inflammation of the anterior spinal soft tissue at the cricopharyngeal opening, thus inhibiting the opening of the UES \[[@b17-arm-2019-43-1-27]\]. It has been reported that the upper esophageal sphincter opening width is significantly increased, along with an improvement of hyoid movement after surgical treatment of ACOs \[[@b3-arm-2019-43-1-27]\]. Consistent with other studies, all patients in the surgical group of the present study had ACOs at C3--C5 level and showed laryngeal penetration, decreased laryngeal elevation, reduced epiglottis inversion, and incomplete UES opening. Moreover, ACO was significantly thicker in the surgical group. Therefore, upper cervical spine alterations, severity of the pharyngeal dysphagia, and ACO thickness might need to be considered when deciding for appropriate treatment options.

Although beneficial effects of surgical removal have been reported, surgical management of ACOs in dysphagia patients is still being debated. Post-surgical soft tissue edema and laryngeal nerve damage can occur. Therefore, there is a chance that surgery can actually degrade swallowing \[[@b24-arm-2019-43-1-27]\]. If there are long-term progressive bone formation and irreversible surrounding tissue changes, it is impossible to completely resolve dysphagia through surgery \[[@b25-arm-2019-43-1-27]\]. Therefore, it is important to establish a proper surgical indication. In an attempt to assist with decisionmaking, correlations between treatment options and various factors were analyzed. If patients' pharyngeal dysphagia and incomplete UES opening are severe, they are more likely to undergo active treatment such as surgery and swallow rehabilitation rather than with conservative treatment.

This study has several limitations. First, it was conducted retrospectively using EMR of subjects. For this reason, selection bias could not be ruled out. Second, the number of subjects was small which limited the study's validity. Third, VFSS follow-up was not performed for all patients after treatment. Therefore, it could not fully evaluate changes of VFSS findings.

In conclusion, the main swallowing characteristics in patients with ACOs were dysphagia features of pharyngeal phase including inappropriate airway protection, decreased laryngeal elevation, and reduced epiglottis inversion. When deciding on a treatment option, considering the severity of dysphagia, specifically at the pharyngeal phase, and the overall osteophyte thickness might be helpful.

No potential conflict of interest relevant to this article was reported.
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###### 

Demographics and clinical characteristics of dysphagic patients with ACO

                                                                                Total (n=23)   Group A (n=4)   Group B (n=9)   Group C (n=10)   p-value
  ----------------------------------------------------------------------------- -------------- --------------- --------------- ---------------- ----------------------------------------------------------
  Sex                                                                                                                                           1.000
   Male                                                                         22             4               9               9                
   Female                                                                       1              0               0               1                
  Etiology                                                                                                                                      0.298
   DISH                                                                         11             3               5               3                
   Osteoarthritis                                                               12             1               4               7                
  Age (yr)                                                                      78.69±8.01     75.25±7.56      82.56±7.19      76.60±7.46       0.191
  Dysphagia duration (day)                                                      96.91±205.19   116.75±114.38   22.22±16.66     155.30±282.48    0.948
   \<1 month                                                                    16             2               6               8                
   1--3 months                                                                  4              1               3               0                
   \>3 months                                                                   3              1               0               2                
  Clinical dysphagia symptoms                                                                                                                   
   Tracheostomy                                                                 1 (4.4)        1 (25)          0               0                0.174
   Aspiration                                                                   16 (69.6)      3 (75)          9 (100)         5 (50)           0.035^[\*](#tfn2-arm-2019-43-1-27){ref-type="table-fn"}^
   Lip sealing^[a)](#tfn1-arm-2019-43-1-27){ref-type="table-fn"}^               3 (13)         0               2 (22.2)        1 (10)           0.771
   Chewing and mastication^[a)](#tfn1-arm-2019-43-1-27){ref-type="table-fn"}^   11 (47.8)      0               5 (55.6)        6 (60)           0.156
   Tongue protrusion^[a)](#tfn1-arm-2019-43-1-27){ref-type="table-fn"}^         9 (39.1)       0               3 (33.3)        5 (50)           0.273
   Laryngeal elevation^[a)](#tfn1-arm-2019-43-1-27){ref-type="table-fn"}^       20 (87)        3 (75)          9 (100)         8 (80)           0.365
   Reflex coughing                                                              14 (60.9)      3 (75)          6 (66.6)        5 (50)           0.630
  Other symptoms                                                                                                                                
   Neck pain                                                                    0              0               0               0                1.000
   Dysphonia                                                                    1 (4.4)        1 (25)          0               0                0.174
   Choking                                                                      20 (87)        4 (100)         8 (88.9)        8 (80)           1.000
   Myelopathy                                                                   0              0               0               0                1.000
   Respiratory insufficiency                                                    1 (4.4)        1 (25)          0               0                0.174
   Aspiration pneumonia                                                         14 (60.9)      1 (25)          6 (66.7)        7 (70)           0.386
   Radiculopathy                                                                1 (4.4)        1 (25)          0               0                0.174
   Reflux                                                                       0              0               0               0                1.000
  Comorbidity                                                                                                                                   
   Hypertension                                                                 7 (30.4)       1 (25)          2 (22.2)        4 (40)           0.836
   Type 2 DM                                                                    5 (21.7)       0               2 (22.2)        3 (30)           0.807
   CAD                                                                          6 (26.1)       1 (25)          2 (22.2)        3 (30)           1.000
   Obesity                                                                      0              0               0               0                1.000
   COPD                                                                         4 (17.4)       0               1 (11.1)        3 (30)           0.471
   Arrhythmia                                                                   5 (21.7)       1 (25)          2 (22.2)        2 (20)           1.000
   Arthritis                                                                    23 (100)       4 (100)         9 (100)         10 (100)         1.000

Values are presented as mean±standard deviation or number (%).

ACO, anterior cervical osteophyte; DISH, diffuse idiopathic skeletal hyperostosis; DM, diabetes mellitus; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.

The parameter of clinical dysphagia symptoms indicates inadequate case.

p\<0.05.

###### 

Radiologic findings of ACO

                                   Total (n=23)   Group A (n=4)   Group B (n=9)   Group C (n=10)   p-value
  -------------------------------- -------------- --------------- --------------- ---------------- ------------------------------------------------------------
  The most affected level          C5 (n=18)      C3-4-5 (n=4)    C5 (n=8)        C5-6 (n=7)       
   C2                              1              1               0               0                0.174
   C3                              12             4               5               3                0.076
   C4                              16             4               7               5                0.242
   C5                              20             4               8               8                1.000
   C6                              18             3               7               8                1.000
   C7                              5              1               1               3                0.483
   T1                              0              0               0               0                1.000
  The thickest level               C5 (n=8)       C4 (n=3)        C5 (n=4)        C5 (n=3)         
   C2                              0              0               0               0                1.000
   C3                              3              0               0               3                0.182
   C4                              5              3               2               0                0.009^[\*\*](#tfn4-arm-2019-43-1-27){ref-type="table-fn"}^
   C5                              8              1               4               3                0.856
   C6                              6              0               3               3                0.679
   C7                              1              0               0               1                1.000
   T1                              0              0               0               0                1.000
  Number of involved vertebra      3.00±1.44      4.00±1.41       3.11±1.37       2.50±1.28        0.217
  Mean osteophyte thickness (mm)   9.07±3.84      13.13±2.26      7.83±2.92       8.55±3.93        0.010^[\*](#tfn3-arm-2019-43-1-27){ref-type="table-fn"}^
  Osteophyte type                                                                                  
   Segmental                       9 (39.1)       0               4 (44.4)        5 (50)           0.295
   Continuous                      7 (30.4)       1 (25)          3 (33.3)        3 (30)           1.000
   Mixed                           7 (30.4)       3 (75)          2 (22.2)        2 (20)           0.137

Values are presented as mean±standard deviation or number (%).

ACO, anterior cervical osteophyte; C, cervical spine; T, thoracic spine.

p\<0.05,

p\<0.01.

###### 

Dysphagia severity and swallowing characteristics in ACO patients

                                     Total (n=23)   Group A (n=4)   Group B (n=9)   Group C (n=10)   p-value
  ---------------------------------- -------------- --------------- --------------- ---------------- ----------------------------------------------------------
  CDS                                38.96±17.45    45.00±26.77     43.44±14.81     32.5±15.1        0.308
  ASHA NOMS swallowing scale         2.17±1.58      2±1.22          1.44±1.25       2.90±1.64        0.123
  VDS                                                                                                
   Total                             40.04±10.06    44.75±6.58      39.83±7.87      38.35±12.17      0.595
   Oral phase                        8.37±7.74      4.88±6.82       6.44±6.63       11.5±7.84        0.246
   Pharyngeal phase                  31.67±9.17     39.88±4.16      33.39±7.23      26.85±9.32       0.041^[\*](#tfn5-arm-2019-43-1-27){ref-type="table-fn"}^
  VFSS findings                                                                                      
   In adequate bolus formation       10 (43.5)      1 (25)          2 (22.2)        7 (70)           0.079
   Premature bolus loss              14 (60.9)      2 (50)          4 (44.4)        8 (80)           0.336
   Decreased laryngeal elevation     21 (91.3)      4 (100)         9 (100)         8 (80)           0.644
   Reduced epiglottis inversion      20 (87.0)      4 (100)         9 (100)         7 (70)           0.182
   Aspiration                        12 (52.2)      3 (75)          6 (66.7)        3 (30)           0.209
   Penetration                       23 (100)       4 (100)         9 (100)         10 (100)         1.000
   Residue in the valleculae         19 (82.6)      4 (100)         7 (77.8)        8 (80)           1.000
   Residue in the pyriform sinuses   19 (82.6)      4 (100)         8 (88.9)        7 (70)           0.471
   Incomplete UES opening            9 (39.1)       4 (100)         3 (33.3)        2 (20)           0.016^[\*](#tfn5-arm-2019-43-1-27){ref-type="table-fn"}^
  Oral transit time (s)              1.84±1.49      1.38±0.50       1.97±1.87       1.89±1.33        0.815
  Pharyngeal delay time (s)          0.29±0.35      0.39±0.35       0.42±0.44       0.14±0.14        0.345
  Pharyngeal transit time (s)        1.33±0.50      1.77±0.36       1.25±0.55       1.24±0.41        0.177

Values are presented as mean±standard deviation or number (%).

ACO, anterior cervical osteophyte; CDS, clinical dysphagia scale; ASHA NOMS, American Speech-Language-Hearing Association National Outcome Measurement System; VDS, videofluoroscopic dysphagia scale; VFSS, videofluoroscopic swallowing study; UES, upper esophageal sphincter.

p\<0.05.

###### 

Comparison of dysphagia severity at 3 months after the initial VFSS

  Variable                     Group A (n=4)   Group B (n=9)   Group C (n=10)   Between group p-value
  ---------------------------- --------------- --------------- ---------------- ------------------------------------------------------------
  ASHA NOMS swallowing scale                                                    
   Baseline                    2.00±1.22       1.44±1.25       2.90±1.64        0.123
   3 months later              5.25±1.26       1.67±1.41       3.70±2.16        0.009^[\*\*](#tfn7-arm-2019-43-1-27){ref-type="table-fn"}^
   Intra-group p-value         0.059           0.655           0.302            
  VFSS follow-up patients      2               5               3                
  VDS                                                                           
   Baseline                    44.75±6.58      39.83±7.87      38.35±12.17      0.595
   Follow-up                   23.70±11.67     39.1±10.22      38.33±6.21       0.035^[\*](#tfn6-arm-2019-43-1-27){ref-type="table-fn"}^
   Intra-group p-value         0.5             0.625           1.0              
  Change of VDS                27.0±6.36       1.9±8.61        1.5±6.87         0.014\*

Values are presented as mean±standard deviation.

ACO, anterior cervical osteophyte; ASHA NOMS, American speech-Language-Hearing Association National Outcome Measurement System; VFSS, videofluoroscopic swallowing study; VDS, videofluoroscopic dysphagia scale.

p\<0.05,

p\<0.01.

###### 

Correlations between treatment options and various characteristics

  Dependent variable   Independent variable               Rho (r)   p-value
  -------------------- ---------------------------------- --------- ----------------------------------------------------------
  Treatment options    Sex                                0.226     0.300
                       Age                                0.079     0.720
                       Aspiration symptom                 0.371     0.081
                       Thickness                          0.348     0.104
                       Osteophyte level                             
                        C3                                0.476     0.022^[\*](#tfn8-arm-2019-43-1-27){ref-type="table-fn"}^
                        C4                                0.408     0.053
                        C5                                0.211     0.335
                        C6                                -0.043    0.846
                        C7                                -0.218    0.318
                       Number of involved vertebra        0.369     0.083
                       CDS                                0.292     0.103
                       VDS                                          
                        Total                             0.257     0.236
                        Oral phase                        -0.340    0.112
                        Pharyngeal phase                  0.505     0.014^[\*](#tfn8-arm-2019-43-1-27){ref-type="table-fn"}^
                       ASHA NOMS swallowing scale         -0.325    0.131
                       VFSS findings                                
                        In adequate bolus formation       -0.429    0.041^[\*](#tfn8-arm-2019-43-1-27){ref-type="table-fn"}^
                        Premature bolus loss              -0.305    0.157
                        Decreased laryngeal elevation     0.327     0.128
                        Reduced epiglottis inversion      0.411     0.052
                        Aspiration                        0.383     0.071
                        Residue in the valleculae         0.131     0.551
                        Residue in the pyriform sinuses   0.309     0.152
                        Incomplete UES opening            0.494     0.017^[\*](#tfn8-arm-2019-43-1-27){ref-type="table-fn"}^
                       Oral transit time                  0.003     0.990
                       Pharyngeal delay time              0.312     0.147
                       Pharyngeal transit time            0.353     0.098

Rho (r), Spearman rank correlation coefficient; CDS, clinical dysphagia scale; VDS, videofluoroscopic dysphagia scale; ASHA NOMS, American Speech-Language-Hearing Association National Outcome Measurement System; VFSS, videofluoroscopic swallowing study; UES, upper esophageal sphincter.

p\<0.05.
